Reva E. Schneider
Oncology | Hospital Medicine
3600 Gaston Avenue
Suite 550, Wadley Tower
Dallas, TX 75246
Suite 550, Wadley Tower
Dallas, TX 75246
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 5 publications
A Phase 1 First-Time-in-Human, Open-Label Study of Nelistotug Administered to Patients with Advanced Solid Tumors.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: November 27, 2025
A First-in-Human Study of Givastomig, a CLDN18.2 and 4-1BB Bispecific Antibody, as Monotherapy in Patients with CLDN18.2-Positive Advanced or Metastatic Solid Tumors.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: December 31, 2024
Intratumoral or Subcutaneous MK-2118, a Noncyclic Dinucleotide STING Agonist, with or without Pembrolizumab, for Advanced or Metastatic Solid Tumors or Lymphomas.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: September 04, 2024
Safety and Clinical Activity of MEDI0562, a Humanized OX40 Agonist Monoclonal Antibody, in Adult Patients with Advanced Solid Tumors.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: September 25, 2019
Pilot Trial of FANG Immunotherapy in Ewing's Sarcoma.
Journal: Molecular therapy : the journal of the American Society of Gene Therapy
Published: December 23, 2014
Showing 1-5 of 5
Last Updated: 09/26/2026